Krüppel-like factor 2 promotes liver steatosis through upregulation of CD36

Journal of Lipid Research

Volumn 55, Issue 1, 2014, Pages 32-40

  Chen, Jin Lian ^a   Lu, Xiao Jie ^a   Zou, Kai Lin ^a   Ye, Kun ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Fatty acid uptake; Kr ppel like factor 2; Nonalcoholic fatty liver disease

Indexed keywords

CD36 ANTIGEN; KRUPPEL LIKE FACTOR 2; MESSENGER RNA; TRIACYLGLYCEROL;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; C57BL 6 MOUSE; CONTROLLED STUDY; DISEASE COURSE; FATTY LIVER; LIPID STORAGE; MALE; MOLECULAR GENETICS; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; UPREGULATION;

FATTY ACID UPTAKE; KRÜPPEL-LIKE FACTOR 2; NONALCOHOLIC FATTY LIVER DISEASE;

ANIMALS; ANTIGENS, CD36; FATTY LIVER; GENE EXPRESSION REGULATION; HYPERTRIGLYCERIDEMIA; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC;

EID: 84891359745     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M039453     Document Type: Article

References (27)

1. Marchesini, G., E. Bugianesi, G. Forlani, F. Cerrelli, M. Lenzi, R. Manini, S. Natale, E. Vanni, N. Villanova, N. Melchionda, et al . 2003 . Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology . 37 : 917-923 .
2. Adams, L. A., J. F. Lymp, J. St Sauver, S. O. Sanderson, K. D. Lindor, A. Feldstein, and P. Angulo . 2005 . The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology . 129 : 113-121 .
3. Petersen, K. F., S. Dufour, J. Feng, D. Befroy, J. Dziura, C. Dalla Man, C. Cobelli, and G. I. Shulman . 2006 . Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian- Indian men. Proc. Natl. Acad. Sci. USA . 103 : 18273-18277 .
4. Korenblat, K. M., E. Fabbrini, B. S. Mohammed, and S. Klein . 2008 . Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology . 134 : 1369-1375 .
5. Cohen, J. C., J. D. Horton, and H. H. Hobbs . 2011 . Human fatty liver disease: old questions and new insights. Science . 332 : 1519-1523 .
6. Fabbrini, E., S. Sullivan, and S. Klein . 2010 . Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology . 51 : 679-689 .
7. Nielsen, S., Z. Guo, C. M. Johnson, D. D. Hensrud, and M. D. Jensen . 2004 . Splanchnic lipolysis in human obesity. J. Clin. Invest. 113 : 1582-1588 .
8. Mittendorfer, B., F. Magkos, E. Fabbrini, B. S. Mohammed, and S. Klein . 2009 . Relationship between body fat mass and free fatty acid kinetics in men and women. Obesity (Silver Spring) . 17 : 1872-1877 .
9. Greco, D., A. Kotronen, J. Westerbacka, O. Puig, P. Arkkila, T. Kiviluoto, S. Laitinen, M. Kolak, R. M. Fisher, A. Hamsten, et al . 2008 . Gene expression in human NAFLD. Am. J. Physiol. Gastrointest. Liver Physiol. 294 : G1281-G1287 .
10. Fabbrini, E., F. Magkos, B. S. Mohammed, T. Pietka, N. A. Abumrad, B. W. Patterson, A. Okunade, and S. Klein . 2009 . Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. USA . 106 : 15430-15435 .
11. Inoue, M., T. Ohtake, W. Motomura, N. Takahashi, Y. Hosoki, S. Miyoshi, Y. Suzuki, H. Saito, Y. Kohgo, and T. Okumura . 2005 . Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice. Biochem. Biophys. Res. Commun. 336 : 215-222 .
12. McConnell, B. B., and V. W. Yang . 2010 . Mammalian Kruppel-like factors in health and diseases. Physiol. Rev. 90 : 1337-1381 .
13. Chiplunkar, A. R., T. K. Lung, Y. Alhashem, B. A. Koppenhaver, F. N. Salloum, R. C. Kukreja, J. L. Haar, and J. A. Lloyd . 2013 Kruppel-like factor 2 is required for normal mouse cardiac development. PLoS ONE . 8 : e54891 .
14. Lin, Z., V. Natesan, H. Shi, F. Dong, D. Kawanami, G. H. Mahabeleshwar, G. B. Atkins, L. Nayak, Y. Cui, J. H. Finigan, et al . 2010 . Kruppel-like factor 2 regulates endothelial barrier function. Arterioscler. Thromb. Vasc. Biol. 30 : 1952-1959 .
15. Marrone, G., L. Russo, E. Rosado, D. Hide, G. Garcia-Cardena, J. C. Garcia-Pagan, J. Bosch, and J. Gracia-Sancho . 2013 . The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins. J. Hepatol. 58 : 98-103 .
16. Tsuchiya, H., Y. Ikeda, Y. Ebata, C. Kojima, R. Katsuma, T. Tsuruyama, T. Sakabe, K. Shomori, N. Komeda, S. Oshiro, et al . 2012 . Retinoids ameliorate insulin resistance in a leptin-dependent manner in mice. Hepatology . 56 : 1319-1330 .
17. Bieghs, V., K. Wouters, P. J. van Gorp, M. J. Gijbels, M. P. de Winther, C. J. Binder, D. Lutjohann, M. Febbraio, K. J. Moore, M. van Bilsen, et al . 2010 . Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology. 138: 2477-2486.
18. Bieghs, V., P. J. van Gorp, S. M. Walenbergh, M. J. Gijbels, F. Verheyen, W. A. Buurman, D. E. Briles, M. H. Hofker, C. J. Binder, and R. Shiri-Sverdlov . 2012 . Specifi c immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice. Hepatology . 56 : 894-903 .
19. Degrace, P., B. Moindrot, I. Mohamed, J. Gresti, Z. Y. Du, J. M. Chardigny, J. L. Sebedio, and P. Clouet . 2006 . Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR - / - apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid. J. Lipid Res. 47 : 2647-2655 .
20. Koonen, D. P., R. L. Jacobs, M. Febbraio, M. E. Young, C. L. Soltys, H. Ong, D. E. Vance, and J. R. Dyck . 2007 . Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes . 56 : 2863-2871 .
21. Zhou, J., Y. Zhai, Y. Mu, H. Gong, H. Uppal, D. Toma, S. Ren, R. M. Evans, and W. Xie . 2006 . A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. J. Biol. Chem. 281 : 15013-15020 .
22. Zhou, J., M. Febbraio, T. Wada, Y. Zhai, R. Kuruba, J. He, J. H. Lee, S. Khadem, S. Ren, S. Li, et al . 2008 . Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology . 134 : 556-567 .
23. Lee, J. H., T. Wada, M. Febbraio, J. He, T. Matsubara, M. J. Lee, F. J. Gonzalez, and W. Xie . 2010 . A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis. Gastroenterology . 139 : 653-663 .
24. Sue, N., B. H. Jack, S. A. Eaton, R. C. Pearson, A. P. Funnell, J. Turner, R. Czolij, G. Denyer, S. Bao, J. C. Molero-Navajas, et al . 2008 . Targeted disruption of the basic Kruppel-like factor gene (Klf3) reveals a role in adipogenesis. Mol. Cell. Biol. 28 : 3967-3978 .
25. Birsoy, K., Z. Chen, and J. Friedman . 2008 . Transcriptional regulation of adipogenesis by KLF4. Cell Metab. 7 : 339-347 .
26. Oishi, Y., I. Manabe, K. Tobe, K. Tsushima, T. Shindo, K. Fujiu, G. Nishimura, K. Maemura, T. Yamauchi, N. Kubota, et al . 2005 . Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab. 1 : 27-39 .
27. Takashima, M., W. Ogawa, K. Hayashi, H. Inoue, S. Kinoshita, Y. Okamoto, H. Sakaue, Y. Wataoka, A. Emi, Y. Senga, et al . 2010 . Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action. Diabetes . 59 : 1608-1615 .